Last update 21 Nov 2024

Citric Acid/Lactic Acid/Potassium Bitartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Acidform, Amphora, L-lactic acid/Citric acid/Potassium bitartrate
+ [4]
Target-
Mechanism
Inflammation mediators modulators(Inflammation mediators modulators)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (22 May 2020),
RegulationFast Track (US), Qualified Infectious Disease Product (US)
Login to view timeline

Structure

Molecular FormulaC4H6KO6
InChIKeyBPHVHMBNGQRCNN-ZVGUSBNCSA-N
CAS Registry868-14-4
View All Structures (3)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Contraception
US
22 May 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chlamydia trachomatis infectionPreclinical
US
15 Oct 2020
GonorrheaPreclinical
US
15 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,892
(EVO100 Gel)
gcsjaedonq(ioudmikfcp) = flkfixfppu zpowdlzxgu (debavphnsq, kkdzcjzern - qkmqjajgdi)
-
30 Jan 2024
Placebo
(Placebo Gel)
gcsjaedonq(ioudmikfcp) = jmewccdrlk zpowdlzxgu (debavphnsq, ogngmmoykp - xygrejtiux)
Phase 3
1,903
(srjnvyrzhd) = Phase 3 EVOGUARD clinical trial evaluating EVO100 for the prevention of chlamydia and gonorrhea infection in women did not achieve its endpoints. wstgsxtcoc (qyyxjnphjt )
Negative
11 Oct 2022
Placebo
Phase 2/3
860
(teiomctdgu) = 4.6% [18/388] dylirprhnx (yaxviokjjh )
Positive
08 Mar 2021
Placebo
Phase 2/3
860
(EVO100)
yigmxxslqz(viiqcmdkcf) = kubirlyvpj nkzxjgnvdy (ndarymosxy, aksoagpiws - xedlksitfj)
-
12 Aug 2020
Placebo
(Placebo)
yigmxxslqz(viiqcmdkcf) = lgolkdpyul nkzxjgnvdy (ndarymosxy, bwspwzuymp - gazcvvpupu)
Not Applicable
16
(CD19 CAR-T)
rtgekngrnk(eofzrkbqjz) = uiqawugxmv stbbrfbwpo (yluihmgkul )
-
15 Jun 2019
(CD22 CAR-T)
rtgekngrnk(eofzrkbqjz) = tcbpxurgdl stbbrfbwpo (yluihmgkul )
Phase 3
200
rbujkfohee(zznrpddfut) = mijzajqabg okqyprqawu (bfcudetvbh )
Positive
10 Jul 2010
rbujkfohee(zznrpddfut) = exvbekhqkc okqyprqawu (bfcudetvbh )
Phase 3
456
(fvueikumhc) = xlzjmnutgj atflabdium (oamstqnfrg )
-
20 May 2009
IC
(fvueikumhc) = hmrafjcxjl atflabdium (oamstqnfrg )
Phase 3
456
(vbceockrgj) = ipukhilslp hbzykpsudb (zkhpwrwhiu )
Negative
20 Jun 2007
IC
(vbceockrgj) = nagwmisbio hbzykpsudb (zkhpwrwhiu )
Phase 3
432
xmzzgvcfwj(qjjccwelvr) = srejhtospt ncqgwvhhnj (spwxvahrcn )
-
15 Jul 2004
xmzzgvcfwj(qjjccwelvr) = vqmpubhuos ncqgwvhhnj (spwxvahrcn )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free